Publications by authors named "William Strohl"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

261

Total Likes

12

Extended Reach

599

Social Features

3
S
Structure and function of therapeutic antibodies approved by the US FDA in 2024.
William R Strohl

Antib Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses.
Ashwin Kumar Ramesh, Jwala Priyadarsini Sivaccumar, Xiaohua Ye, Luona Yang, Hailong Guo, William R Strohl

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure and function of therapeutic antibodies approved by the US FDA in 2023.
William R Strohl

Antib Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies.
Hailong Guo, Sha Ha, Jason W Botten, Kai Xu, Ningyan Zhang, William R Strohl

Viruses· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An ACE2 decamer viral trap as a durable intervention solution for current and future SARS-CoV.
Hailong Guo, Bomsoo Cho, Paul R Hinton, Sijia He, Yongjun Yu, William R Strohl

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infections.
Peter T Buckley, Rita Chan, Jeffrey Fernandez, Jinquan Luo, Keenan A Lacey, William R Strohl

Cell Host Microbe· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.
William R Strohl, Zhiqiang Ku, Zhiqiang An, Stephen F Carroll, Bruce A Keyt, Lila M Strohl

BioDrugs· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET.
Joost Neijssen, Rosa M F Cardoso, Kristen M Chevalier, Luus Wiegman, Thomas Valerius, William R Strohl

J Biol Chem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.
William R Strohl, Michael Naso

Antibodies (Basel)· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of biologic agents to neutralize the bicomponent leukocidins of .
Rita Chan, Peter T Buckley, Aidan O'Malley, William E Sause, Francis Alonzo, William R Strohl

Sci Transl Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frontiers and Opportunities: Highlights of the 2 Annual Conference of the Chinese Antibody Society.
Hongyu Zhang, Mi Deng, Peng Lin, Junjian Liu, Cheng Liu, William R Strohl

Antib Ther· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current progress in innovative engineered antibodies.
William R Strohl

Protein Cell· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
Michelle Kinder, Allison R Greenplate, William R Strohl, Robert E Jordan, Randall J Brezski

MAbs· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.
William E Sause, Peter T Buckley, William R Strohl, A Simon Lynch, Victor J Torres

Trends Pharmacol Sci· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysfunctional Antibodies in the Tumor Microenvironment Associate with Impaired Anticancer Immunity.
Ningyan Zhang, Hui Deng, Xuejun Fan, Anneliese Gonzalez, Songlin Zhang, William Strohl

Clin Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing production of Fc-amidated peptides by Chinese hamster ovary cells.
Kristina Carlson, Steven C Pomerantz, Omid Vafa, Michael Naso, William Strohl

BMC Biotechnol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters.
William R Strohl

BioDrugs· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretion of Fc-amidated peptide fusion proteins by Chinese hamster ovary cells.
Kristina R Carlson, Steven C Pomerantz, Jiali Li, Omid Vafa, Michael Naso, William Strohl

BMC Biotechnol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages.
Yun Shi, Xuejun Fan, Hui Deng, Randall J Brezski, Michael Rycyzyn, William R Strohl

J Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel therapeutic strategy to rescue the immune effector function of proteolytically inactivated cancer therapeutic antibodies.
Xuejun Fan, Randall J Brezski, Hui Deng, Pooja M Dhupkar, Yun Shi, William R Strohl

Mol Cancer Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody discovery: sourcing of monoclonal antibody variable domains.
William R Strohl

Curr Drug Discov Technol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modern therapeutic antibody drug discovery technologies.
William R Strohl

Curr Drug Discov Technol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential therapeutic roles for antibody mixtures.
T Shantha Raju, William R Strohl

Expert Opin Biol Ther· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered protease-resistant antibodies with selectable cell-killing functions.
Michelle Kinder, Allison R Greenplate, Katharine D Grugan, Keri L Soring, Katharine A Heeringa, William R Strohl

J Biol Chem· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis